Anna Miczke

405 total citations
26 papers, 335 citations indexed

About

Anna Miczke is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Endocrine and Autonomic Systems. According to data from OpenAlex, Anna Miczke has authored 26 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 5 papers in Public Health, Environmental and Occupational Health and 3 papers in Endocrine and Autonomic Systems. Recurrent topics in Anna Miczke's work include Adipokines, Inflammation, and Metabolic Diseases (11 papers), Nutrition and Health Studies (4 papers) and Regulation of Appetite and Obesity (3 papers). Anna Miczke is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (11 papers), Nutrition and Health Studies (4 papers) and Regulation of Appetite and Obesity (3 papers). Anna Miczke collaborates with scholars based in Poland and United States. Anna Miczke's co-authors include Danuta Pupek‐Musialik, Maciej Owecki, Paweł Bogdański, Joanna Suliburska, Monika Szulińska, Jarosław Walkowiak, J Sowiński, Matylda Kręgielska-Narożna, Rita Hansdorfer-Korzon and Ewa Miller‐Kasprzak and has published in prestigious journals such as Journal of Hypertension, Hormone and Metabolic Research and Experimental and Clinical Endocrinology & Diabetes.

In The Last Decade

Anna Miczke

24 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Miczke Poland 8 117 110 65 46 46 26 335
Shima Taherkhani Iran 5 138 1.2× 113 1.0× 20 0.3× 56 1.2× 27 0.6× 6 358
L Bonnet France 14 229 2.0× 211 1.9× 27 0.4× 37 0.8× 49 1.1× 29 655
Roxana Carbó Mexico 11 111 0.9× 85 0.8× 12 0.2× 48 1.0× 71 1.5× 27 377
Hideki Nojima Japan 5 147 1.3× 179 1.6× 69 1.1× 67 1.5× 62 1.3× 10 363
Melinda Phang Australia 13 196 1.7× 78 0.7× 17 0.3× 80 1.7× 120 2.6× 25 652
Roel A. van der Heijden Netherlands 7 169 1.4× 134 1.2× 39 0.6× 27 0.6× 46 1.0× 7 398
Kimberly R. Coenen United States 9 139 1.2× 195 1.8× 55 0.8× 54 1.2× 33 0.7× 10 352
Anton Kebis Slovakia 9 80 0.7× 27 0.2× 14 0.2× 16 0.3× 44 1.0× 18 264
Alice Bongrani France 11 95 0.8× 102 0.9× 52 0.8× 59 1.3× 61 1.3× 17 519
Mahtab Zarei Iran 12 55 0.5× 19 0.2× 9 0.1× 15 0.3× 24 0.5× 23 304

Countries citing papers authored by Anna Miczke

Since Specialization
Citations

This map shows the geographic impact of Anna Miczke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Miczke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Miczke more than expected).

Fields of papers citing papers by Anna Miczke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Miczke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Miczke. The network helps show where Anna Miczke may publish in the future.

Co-authorship network of co-authors of Anna Miczke

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Miczke. A scholar is included among the top collaborators of Anna Miczke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Miczke. Anna Miczke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Szulińska, Monika, Magdalena Gibas-Dorna, Ewa Miller‐Kasprzak, et al.. (2017). Spirulina maxima improves insulin sensitivity, lipid profile, and total antioxidant status in obese patients with well-treated hypertension: a randomized double-blind placebo-controlled study.. PubMed. 21(10). 2473–2481. 78 indexed citations
2.
Miczke, Anna, Monika Szulińska, Rita Hansdorfer-Korzon, et al.. (2016). Effects of spirulina consumption on body weight, blood pressure, and endothelial function in overweight hypertensive Caucasians: a double-blind, placebo-controlled, randomized trial.. PubMed. 20(1). 150–6. 73 indexed citations
3.
Miczke, Anna, Joanna Suliburska, Danuta Pupek‐Musialik, et al.. (2015). Effect of L-arginine supplementation on insulin resistance and serum adiponectin concentration in rats with fat diet.. PubMed. 8(7). 10358–66. 26 indexed citations
4.
Owecki, Maciej, et al.. (2011). Serum resistin concentrations are associated with HbA1c in obese non-diabetics, but not in obese diabetics: a cross-sectional human study.. PubMed. 32(3). 349–53. 4 indexed citations
5.
Owecki, Maciej, et al.. (2010). Free leptin index as a marker for leptin action in diabetes and obesity: leptin and soluble leptin receptors relationship with HbA1c.. PubMed. 31(5). 679–83. 7 indexed citations
7.
Owecki, Maciej, et al.. (2010). Serum resistin is related to plasma HDL cholesterol and inversely correlated with LDL cholesterol in diabetic and obese humans.. PubMed. 31(5). 673–8. 18 indexed citations
8.
Owecki, Maciej, et al.. (2010). Serum Resistin Concentrations are Higher in Human Obesity but Independent from Insulin Resistance. Experimental and Clinical Endocrinology & Diabetes. 119(2). 117–121. 40 indexed citations
9.
Bryl, Wiesław, et al.. (2008). The assessment of adiponectin and insulin concentrations selected metabolic parameters, family history and anthropometric factors in young population with primary arterial hypertension. Arterial Hypertension. 12(5). 359–366. 1 indexed citations
10.
Bryl, Wiesław, et al.. (2008). Ocena grubości kompleksu intima–media i wybranych parametrów metabolicznych w populacji młodych osób z nadciśnieniem tętniczym pierwotnym. Arterial Hypertension. 12(4). 285–290. 1 indexed citations
11.
Bryl, Wiesław, et al.. (2008). Leptin and insulin concentrations, lipid profile and anthropometric parameters in young adults with primary arterial hypertension. Arterial Hypertension. 12(6). 424–431. 1 indexed citations
12.
Owecki, Maciej, et al.. (2008). Serum Adiponectin Concentrations are not Related to Glycosylated Hemoglobin Levels (HbA1c) in Obese Diabetic and Non-diabetic Caucasians. Experimental and Clinical Endocrinology & Diabetes. 116(3). 173–177. 5 indexed citations
13.
Owecki, Maciej, et al.. (2007). Circulating Serum Adiponectin Concentrations do not Differ between Obese and Non-obese Caucasians and are Unrelated to Insulin Sensitivity. Hormone and Metabolic Research. 39(1). 25–30. 10 indexed citations
14.
Owecki, Maciej, Anna Miczke, Marta Kaczmarek-Ryś, et al.. (2007). The Y111 H (T415C) Polymorphism in Exon 3 of the Gene Encoding Adiponectin is Uncommon in Polish Obese Patients. Hormone and Metabolic Research. 39(11). 797–800. 6 indexed citations
15.
Owecki, Maciej, et al.. (2007). Serum adiponectin concentrations and their relationship with plasma lipids in obese diabetic and non-diabetic Caucasians.. PubMed. 28(6). 901–7. 5 indexed citations
16.
Bryl, Wiesław, et al.. (2006). Obesity of children and adolescents – epidemiology, consequences and prevention. Przewodnik Lekarza/Guide for GPs. 9(9). 91–95. 4 indexed citations
17.
Szulińska, Monika, Danuta Pupek‐Musialik, Paweł Bogdański, Wiesław Bryl, & Anna Miczke. (2006). Evaluation of insulin resistance - euglicemic clamp in hypertensive patients. Arterial Hypertension. 10(1). 43–50. 1 indexed citations
18.
Miczke, Anna, Wiesław Bryl, Paweł Bogdański, et al.. (2005). The assessment of adiponectin in patients with acute coronary disease. Arterial Hypertension. 9(1). 31–36. 1 indexed citations
19.
Bryl, Wiesław, et al.. (2005). [Assessment of blood pressure and endothelin-1 plasma concentration in young, hypertensive patients after treatment with angiotensin converting enzyme inhibitor].. PubMed. 18(107). 524–6. 1 indexed citations
20.
Pupek‐Musialik, Danuta, et al.. (2004). DOES OBESITY INFLUENCE ON LIPOPROTEIN (A) AND FIBRINOGEN LEVEL IN PATIENTS WITH HYPERTENSIONquest;. Journal of Hypertension. 22(Suppl. 2). S91–S91. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026